R. Rassir, M. Schuiling, I. N. Sierevelt, C. W. P. van der Hoeven, P. A. Nolte, Department of Orthopaedic Surgery, Spaarne Gasthuis, Hoofddorp, the Netherlands.
Clin Orthop Relat Res. 2021 Apr 1;479(4):755-763. doi: 10.1097/CORR.0000000000001541.
Bone cement implantation syndrome (BCIS) is characterized by hypoxia, hypotension, and the loss of consciousness during cemented arthroplasty; it may result in death. Its incidence has only been explored for hemiarthroplasty and THA after fracture or cancer. To our knowledge, there are no studies that comprehensively explore and compare the incidence of BCIS in other arthroplasty procedures.
QUESTIONS/PURPOSES: (1) To report the incidence of BCIS in TKA, unicondylar knee arthroplasty, hip hemiarthroplasty, THA, shoulder arthroplasty, TKA, and revision THA and TKA; (2) to determine whether severe BCIS is associated with an increased risk of death within 30 days of surgery; and (3) to identify factors associated with the development of severe BCIS.
All patients undergoing cemented arthroplasty for any reason (TKA [11% cemented, 766 of 7293], unicondylar knee arthroplasty [100% cemented, 562 procedures], hip hemiarthroplasty for femur fractures [100% cemented, 969 procedures], THA [8% cemented, 683 of 8447], shoulder arthroplasty [84% cemented, 185 of 219], and revision arthroplasty of the hip and knee [36% cemented, 240 of 660]) between January 2008 and August 2019 were considered for inclusion in the current retrospective observational study. Fixation choice was dependent on surgeon preference (THA and TKA), prosthesis design (shoulder arthroplasty), or bone quality (revision arthroplasty). The following procedures were excluded because of insufficient data: < 1% (1 of 766) of TKAs, 1% (4 of 562) of unicondylar knee arthroplasties, 6% (54 of 969) of hip hemiarthroplasties, 1% (6 of 683) of THAs, 6% (12 of 185) of shoulder arthroplasties, and 14% (34 of 240) of revision procedures. This resulted in a final inclusion of 3294 procedures (765 TKAs [23%], 558 unicondylar knee arthroplasties [17%], 915 hip hemiarthroplasties [28%], 677 THA [21%], 173 shoulder arthroplasties [5%], and 206 revision arthroplasties [6%]), of which 28% (930 of 3294) had an emergent indication for surgery. Of the patients, 68% (2240 of 3294) were females, with a mean age of 75 ± 11 years. All anesthetic records were extracted from our hospital's database, and the severity of BCIS was retrospectively scored (Grade 0 [no BCIS], Grade 1 [O2% < 94% or fall in systolic blood pressure of 20% to 40%], Grade 2 [O2% < 88% or fall in systolic blood pressure of > 40%], and Grade 3 [cardiovascular collapse requiring CPR]). Procedures were dichotomized into no or moderate BCIS (Grades 0 and 1) and severe BCIS (Grades 2 and 3). The adjusted 30-day mortality of patients with severe BCIS was assessed with a multivariate Cox regression analysis. A multivariate logistic regression analysis was performed to identify factors associated with the development of severe BCIS.
BCIS occurred in 26% (845 of 3294) of arthoplasty procedures. The incidence was 31% (282 of 915) in hip hemiarthroplasty, 28% (210 of 765) in TKA, 24% (165 of 677) in THA, 23% (47 of 206) in revision arthroplasty, 20% (113 of 558) in unicondylar knee arthroplasty, and 16% (28 of 173) in shoulder arthroplasty. Patients with severe BCIS were more likely (hazard ratio 3.46 [95% confidence interval 2.07 to 5.77]; p < 0.001) to die within 30 days of the index procedure than were patients with less severe or no BCIS. Factors independently associated with the development of severe BCIS were age older than 75 years (odds ratio 1.57 [95% CI 1.09 to 2.27]; p = 0.02), American Society of Anesthesiologists Class III or IV (OR 1.58 [95% CI 1.09 to 2.30]; p = 0.02), and renal impairment (OR 3.32 [95% CI 1.45 to 7.46]; p = 0.004).
BCIS is common during cemented arthroplasty; severe BCIS is uncommon, but it is associated with an increased risk of death within 30 days of surgery. Medically complex patients undergoing hip hemiarthroplasty may be at particular risk. Patients at high risk for severe BCIS (renal impairment, ASA III/IV, and age older than 75 years) should be identified and preventive measures such as medullary lavage before cementation, femoral venting, and avoidance of excessive pressurization of implants should be taken to reduce the likelihood and consequences of BCIS. Because of the increased risk of periprosthetic fractures in uncemented hip stems, factors associated with the development of BCIS should be weighed against the risk factors for sustaining periprosthetic fractures (poor bone quality, female sex) to balance the risks of fixation method against those of BCIS for each patient.
Level III, therapeutic study.
骨水泥植入综合征(BCIS)的特征是在骨水泥关节置换术中出现缺氧、低血压和意识丧失,可能导致死亡。它的发生率仅在骨折或癌症后行半髋关节置换术和全髋关节置换术(THA)时进行了探讨。据我们所知,目前尚无研究全面探讨和比较其他关节置换术过程中 BCIS 的发生率。
问题/目的:(1)报告 TKA、单髁膝关节置换术、髋关节半髋关节置换术、THA、肩关节置换术、TKA 和翻修 THA 和 TKA 中 BCIS 的发生率;(2)确定严重 BCIS 是否与术后 30 天内死亡的风险增加相关;(3)确定与严重 BCIS 发展相关的因素。
所有因任何原因接受骨水泥关节置换术的患者(TKA[11%骨水泥,7293 例中的 766 例]、单髁膝关节置换术[100%骨水泥,562 例]、股骨骨折的髋关节半髋关节置换术[100%骨水泥,969 例]、THA[8%骨水泥,8447 例中的 683 例]、肩关节置换术[84%骨水泥,185 例中的 185 例]和髋关节和膝关节翻修术[36%骨水泥,660 例中的 240 例])均被纳入本回顾性观察性研究。固定选择取决于外科医生的偏好(THA 和 TKA)、假体设计(肩关节置换术)或骨质量(翻修关节置换术)。由于数据不足,排除了以下手术:<1%(766 例中的 1 例)的 TKA、1%(562 例中的 4 例)的单髁膝关节置换术、6%(969 例中的 54 例)的髋关节半髋关节置换术、1%(683 例中的 6 例)的 THA、6%(185 例中的 12 例)的肩关节置换术和 14%(240 例中的 34 例)的翻修术。这导致最终纳入 3294 例手术(765 例 TKA[23%]、558 例单髁膝关节置换术[17%]、915 例髋关节半髋关节置换术[28%]、677 例 THA[21%]、173 例肩关节置换术[5%]和 206 例翻修术[6%]),其中 28%(3294 例中的 930 例)为急症手术。患者中 68%(3294 例中的 2240 例)为女性,平均年龄为 75±11 岁。所有麻醉记录均从我院数据库中提取,BCIS 的严重程度采用回顾性评分(0 级[无 BCIS]、1 级[O2%<94%或收缩压下降 20%至 40%]、2 级[O2%<88%或收缩压下降>40%]和 3 级[心血管崩溃需要心肺复苏])。将手术分为无或中度 BCIS(0 级和 1 级)和严重 BCIS(2 级和 3 级)。用多变量 Cox 回归分析评估严重 BCIS 患者的 30 天死亡率。采用多变量逻辑回归分析确定与严重 BCIS 发展相关的因素。
3294 例关节置换术中发生 BCIS 26%(845 例)。髋关节半髋关节置换术发生率为 31%(915 例中的 282 例)、TKA 为 28%(765 例中的 210 例)、THA 为 24%(677 例中的 165 例)、翻修术为 23%(206 例中的 47 例)、单髁膝关节置换术为 20%(558 例中的 113 例)和肩关节置换术为 16%(173 例中的 28 例)。严重 BCIS 患者术后 30 天内死亡的风险明显高于轻度或无 BCIS 患者(风险比 3.46[95%置信区间 2.07 至 5.77];p<0.001)。与严重 BCIS 发生相关的独立因素为年龄大于 75 岁(优势比 1.57[95%置信区间 1.09 至 2.27];p=0.02)、美国麻醉师协会分级 III 或 IV(优势比 1.58[95%置信区间 1.09 至 2.30];p=0.02)和肾功能不全(优势比 3.32[95%置信区间 1.45 至 7.46];p=0.004)。
BCIS 在骨水泥关节置换术中很常见;严重 BCIS 不常见,但与术后 30 天内死亡风险增加相关。接受髋关节半髋关节置换术的合并症较多的患者可能风险更高。发生严重 BCIS 的高危患者(肾功能不全、ASA III/IV 和年龄大于 75 岁)应予以识别,并采取髓腔冲洗、股骨通气和避免植入物过度加压等预防措施,以降低 BCIS 的发生几率和后果。由于非骨水泥髋关节假体发生假体周围骨折的风险增加,应权衡与发生 BCIS 相关的因素与发生假体周围骨折(骨质量差、女性)的风险因素,以平衡每种患者的固定方法风险与 BCIS 风险。